Global Drug Delivery Devices Market Size is Projected to Reach $340.45 Billion by 2030, Growing at a CAGR of 7.1%

New York, USA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- According to Strategic Market Research, the Global Drug Delivery Devices Market size in 2021 was USD 239.2 billion, and by 2030 it will be USD 340.45 billion, with a 7.1% CAGR. The formulations, strategies, and techniques used to deliver chemical substances or drugs inside the body are referred to as drug delivery. This is used to treat, diagnose, cure, or prevent several diseases, including diabetes, gastrointestinal disorders, bacterial and viral infections, and allergies. The materials most frequently used to produce drug delivery systems include ethylene vinyl acetate, silicone, polyurethane, acrylate hydrogels, and other biodegradable materials.

Make a Direct Purchase of the latest Drug Delivery Devices Market Report published in the month of Jul-2022. Click the below link to initiate the purchase:

Drug Delivery Devices Market Insights: 

  • By route of administration, the oral segment ruled the overall drug delivery devices market in 2020.
  • In 2020, the cancer segment held a significant position in the market on the basis of application.
  • On the basis of end-user, in 2020, the hospital segment ruled the market with the largest market share.
  • Regionally, North America ruled the overall drug delivery devices market, with a revenue share of around 34% in 2021.

Factors accelerating the Drug Delivery Devices Market growth

The increasing incidence of chronic diseases and the biopharmaceutical industry's growth are driving the market's expansion.

  • The market for drug delivery devices is expected to augment by the increasing prevalence of chronic diseases like cardiovascular conditions, diabetes, cancer, and other illnesses. The World Health Organization estimated that by 2020, chronic diseases would be responsible for nearly 75% of all fatalities worldwide, with developing nations accounting for 71% of deaths from ischemic heart disease (IHD), 75% of deaths from stroke, and 70% of deaths from diabetes.

  • The biopharmaceutical industry's rapid growth is resulting in the creation of numerous new drugs that are beneficial in the treatment of various diseases. The development of novel new drugs is aided by the growing investments made in clinical trials by pharmaceutical companies and the active role taken by various regulatory agencies like the FDA and EMA.

Drug Delivery Devices Market: A thorough Segmentation Analysis

The worldwide Drug Delivery Devices Market segmentation has been performed on the basis of route of administration, Application, End-user, and region.

By Route of Administration:

  • Nasal
  • Inhalation
  • Injectable
  • Topical
  • Oral
  • Ocular
  • Others

By Application:

  • Diabetes
  • Infectious Diseases
  • Cancer
  • Cardiovascular
  • Others

By End-User

  • Home Healthcare
  • Ambulatory Services
  • Hospitals

By Region

North America

  • Canada
  • United States


  • United Kingdom
  • France
  • Germany

Asia Pacific

  • Japan
  • India
  • China
  • South Korea
  • Rest of the World


  • Argentina
  • Israel
  • Brazil
  • Saudi Arabia
  • South America
  • Mexico
  • United Arab Emirates
  • Rest of LAMEA

To get a first-hand overview of the report, Request a Sample at

By route of administration, the oral segment ruled the overall drug delivery devices market in 2020. This is due to the growing popularity of oral drug delivery because it is painless, patient-friendly, non-invasive, cost-effective, and self-administered. Furthermore, most medicines are available in tablet, powder, and liquid forms and are typically administered orally. Therefore, the enormous availability of oral medications has accelerated the segment's growth.

In 2020, the cancer segment held a significant position in the market on the basis of application. The increased incidence of cancer is the main factor stimulating the growth of this market segment. Worldwide cancer cases are estimated to increase by 47% between 2020 and 2040. Globally, 28.4 million cases are predicted to be reported in 2040. Therefore, the main drivers of this market are the rising prevalence of different cancers like breast, lung, womb, and bowel cancer. 
It is predicted that the cardiovascular segment will be the fastest-growing market segment during the projected time. This market segment is expanding as a result of the rising occurrence of CVDs in the population due to unhealthy eating habits and inactivity.

On the basis of end-user, in 2020, the hospital segment ruled the market with the largest market share. The expansion of this market was facilitated by the rising public and private sector investments in hospital construction. Furthermore, the segment's growth is being driven by the increase in hospital admissions rate.

Regionally, North America ruled the overall drug delivery devices market, with a revenue share of around 34% in 2021. This is due to the increasing incidence of chronic diseases in the US, including diabetes, cancer, and CVDs. The US's rising healthcare costs and increased health awareness have accelerated the market's expansion. The growth of drug delivery devices in North America has been significantly aided by the increased awareness of the availability of numerous cutting-edge drug delivery devices, such as pen injectors and wearable injectors.

Report AttributeDetails
Forecast Period2021 - 2030
The market size value in 2021USD 239.2 billion
The revenue forecast in 2030USD 340.45 billion
Growth rateCAGR of 4.0 %
The base year for estimation2021
Historical data2017 – 2020
UnitUSD Billion, CAGR (2021 - 2030)
SegmentationBy Route of Administration, By Application, By End User, By Region
In terms of Route of AdministrationOcular, Oral, Inhalation, Nasal, Injectable, Topical, Others
In Terms of ApplicationDiabetes, Cancer, Infectious Diseases, Cardiovascular, Others
By End-UserAmbulatory Services, Home Healthcare, Hospitals.
By RegionNorth America, Asia Pacific, Europe, and The Rest of the world
Country ScopeCanada, Mexico, US, Germany, the UK, France, India, Japan, China, etc.
Company Usability ProfilesPfizer, Inc, Novartis AG, Bayer AG, Shenzhen (SiBiono) , GeneTech Company Ltd.(Hubei Tongji Benda Ebei Pharma), F. Hoffmann-La Roche, 3M, Johnson & Johnson Services, Antares Pharma, Inc, uniQure N.V,

Drug Delivery Devices Market Report Coverage

Key players in Drug Delivery Devices Market:

  • Medtronic Plc
  • Insulet Corporation
  • Boehringer Ingelheim group
  • Consort Medical Plc
  • AstraZeneca PLC
  • GlaxoSmithKline Plc
  • Antares Pharma, Inc
  • Gene Tech Company Ltd.
  • Shenzhen
  • F. Hoffmann-La Roche
  • Novartis AG
  • 3M
  • Pfizer, Inc
  • uniQure N.V
  • Sulzer Ltd.
  • Johnson & Johnson Services Inc
  • Becton Dickinson
  • Bayers AG

Before initiating a purchase, make a Pre-order enquiry and get a detailed overview of the content of the report.

Recent Developments

  • On October 2022, NuGen Medical Devices Inc., a needle-free drug delivery pioneer, announced the launch of its InsuJetTM devices in Canada.

  • On October 2022, atai Life Sciences, a clinical-stage biopharmaceutical company, announced the start of a Phase one Proof of Concept clinical trial of the intranasal INB 01, which is a sol gel-based excipient drug delivery technology.

  • On October 2022, Becton Dickinson announced its collaboration with Biocorp on connected self-injection devices. They will use connected technology on self-administered medicines, such as biologics, to capture and transmit injection data and monitor patients' adherence to therapy.

Related Reports

Injectable Drug Delivery Market
The Injectable Drug Delivery Market report by SMR analyzes its challenges, growth factors, opportunities, etc. The Injectable Drug Delivery Market in 2021 was $615.87 billion, and it will reach $1677.91 billion by 2030, at an 11.78% CAGR during 2021-2030. An increasing number of chronic diseases, needle injuries, and the usage of injections are influencing the market expansion. Companies working in this market are Gerresheimer, B. Braun Melsungen, Teva Pharmaceuticals Industries Ltd., etc.

Microneedle Drug Delivery Systems Market
SMR's Microneedle Drug Delivery Systems Market Report explains its challenges, restraints, driving factors, etc. The Microneedle Drug Delivery Systems Market value in 2021 was USD 5.71 billion and will reach USD 10.14 billion by 2030, with a 6.5% CAGR. The increasing incidence of obesity and rising investment in healthcare facilities are the factors accelerating the overall growth of this market. Major companies in this market are Endoderma Ltd., Innoture Medical Technology Limited, Zosano Pharma Corporation, etc.

Anesthesia Drug Market
SMR report on the Anesthesia Drug Market studies its restraints, challenges, augmenting factors, etc. The Anesthesia Drug Market worth 2021 was USD 7.03 billion in 2021 and will reach USD 9.56 billion with a 3.47% CAGR. Factors such as the increasing number of surgeries, the rising geriatric population, and technological advancements are boosting market expansion. Businesses operating in this market are Hospira Inc, Pfizer Inc., Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., etc.

Angioplasty Balloons Market
The Angioplasty Balloons Market Report provides insights into its drivers, opportunities, challenges, etc. The Angioplasty Balloons Market in 2021 was USD 2.60 billion and will reach USD 3.73 billion by 2030 at a 4.10% CAGR. 
The increasing incidence of cardiovascular disorders, the rising geriatric population, and the COVID-19 Impact are driving the market's overall growth. Vital players in the market are Medtronic Plc, Cook Medical, Inc., SINOMED, Biotronik, Cardinal Health, etc.

Veterinary Pain Management Market
SMR's Veterinary Pain Management Market report offers a detailed overview of its growth factors, restraints, opportunities, etc. The Veterinary Pain Management Market value in 2021 was USD 1.44 Billion, and it will reach USD 2.92 Billion by 2030 with an 8.12% CAGR. High adoption of diagnostic tools, innovation in vaccines and diagnosis, rise in pet insurance, and increasing pet disease are stimulating the market's overall growth. Major market players in this market are Bayer AG, IDEXX Laboratories, Dechra Pharmaceuticals, Norbrook, BASF SE, Medtronic, ADM Nutreco, etc.

About Us:
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup which is in the Introduction stage of the Product Life cycle or an established one which is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.

Contact Us:
Strategic Market Research LLP.
Sunil Kumar 
India: +91-8260836500
Press Release:

Connect Us: